# BRIUMVI® (ublituximab-xiiy)

> BRIUMVI (ublituximab-xiiy) is a CD20-directed monoclonal antibody from TG Therapeutics, FDA-approved in December 2022 for relapsing forms of multiple sclerosis (RMS). It is administered as a 1-hour intravenous infusion twice per year, following the starting dose. This is the official patient site. See Important Safety Information and full Prescribing Information for complete details.

## About BRIUMVI
- [What is BRIUMVI?](https://briumvi.com/about-briumvi/what-is-briumvi/): How BRIUMVI works as a B-cell (CD20-directed) therapy for relapsing MS, and how it is given.
- [See the Results](https://briumvi.com/about-briumvi/see-the-results/): Efficacy data from the ULTIMATE I and ULTIMATE II Phase 3 studies versus teriflunomide, including relapse-rate and MRI lesion outcomes.
- [Understanding Safety](https://briumvi.com/about-briumvi/understanding-safety/): Important Safety Information, including the most common side effects and infusion reactions.
- [Dosing](https://briumvi.com/about-briumvi/dosing/): The BRIUMVI dosing schedule, including the starting dose and the twice-per-year maintenance infusions.

## Treatment Experience
- [Infusion Experience](https://briumvi.com/infusion-experience/): What to expect before, during, and after a BRIUMVI infusion.

## Patient Support
- [BRIUMVI Patient Support](https://briumvi.com/briumvi-patient-support/): Support services for people prescribed BRIUMVI, including onboarding and ongoing resources.
- [Financial Assistance](https://briumvi.com/financial-assistance/): Cost, coverage, and financial assistance options for eligible patients.
- [Sign Up](https://briumvi.com/sign-up/): Register to receive BRIUMVI updates and support resources.

## Patient Stories
- [Patient Stories](https://briumvi.com/patient-stories/): Real experiences from people living with relapsing MS who are treated with BRIUMVI.

## Optional
- [Full Prescribing Information and Medication Guide (PDF)](https://www.tgtherapeutics.com/label-prescribing-info/uspi-briumvi.pdf)
- [Sitemap index](https://briumvi.com/sitemap_index.xml)